Compare SUNB & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUNB | BNTX |
|---|---|---|
| Founded | 1947 | 2008 |
| Country | United States | Germany |
| Employees | 8402 | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.8B | 24.2B |
| IPO Year | 2026 | 2019 |
| Metric | SUNB | BNTX |
|---|---|---|
| Price | $72.76 | $100.91 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 13 |
| Target Price | $70.75 | ★ $133.46 |
| AVG Volume (30 Days) | ★ 2.1M | 800.8K |
| Earning Date | 06-16-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.44% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.31 | N/A |
| Revenue Next Year | $5.06 | $3.37 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $61.03 | $79.81 |
| 52 Week High | $78.05 | $124.00 |
| Indicator | SUNB | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 52.01 | 52.71 |
| Support Level | $61.77 | $99.08 |
| Resistance Level | N/A | $113.05 |
| Average True Range (ATR) | 2.71 | 3.66 |
| MACD | 0.80 | 0.24 |
| Stochastic Oscillator | 56.75 | 41.11 |
Sunbelt Rentals (formerly UK-based Ashtead Group) is the number two equipment rental company in the US (11% market share), with a smaller presence in Canada and the UK. Sunbelt operates a rental fleet of just over $15 billion across a network of 1,200 stores in the US, nearly CAD 2 billion of fleet and 135 stores in Canada, and GBP 1.1 billion and 190 stores in the UK. The company has experienced rapid growth over the past decade as its customers increasingly turn to rental versus owning equipment outright. The general tool business has been augmented by the Specialty Rental business, which has grown to 30% of the mix. Revenue is now greater than 50% nonconstruction, with the remainder focused more directly on commercial construction.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.